Study of Immunotherapy to Treat Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT00861614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects With Castration Resistant Prostate Cancer That Have Received Prior Treatment With Docetaxel
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine if advanced prostate cancer patients that are treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT alone
Study identification
- NCT ID
- NCT00861614
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 988 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2009
- Primary completion
- Oct 31, 2012
- Completion
- Jul 31, 2015
- Last update posted
- Sep 29, 2016
2009 – 2015
United States locations
- U.S. sites
- 44
- U.S. states
- 24
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center | Mobile | Alabama | 36608 | — |
| Alaska Clinical Research Center, Llc | Anchorage | Alaska | 99508 | — |
| Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85715 | — |
| Highlands Oncology Group, P.A. | Fayetteville | Arkansas | 72703 | — |
| Marsha G. Fink, Md, Inc. | Fountain Valley | California | 92708 | — |
| Loma Linda University Cancer Center | Loma Linda | California | 92350 | — |
| Usc/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Prostate Oncology Specialists, Inc. | Marina del Rey | California | 90292 | — |
| Comprehensive Cancer Center | Palm Springs | California | 92262 | — |
| Va San Diego Healthcare System | San Diego | California | 92161 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| Baptist Cancer Institute | Jacksonville | Florida | 32207 | — |
| Orlando Health, Inc | Orlando | Florida | 32806 | — |
| Suburban Hematology-Oncology Associates, Pc | Lawrenceville | Georgia | 30046 | — |
| University Of Chicago | Chicago | Illinois | 60637 | — |
| Cancer Care Specialists Of Central Illinois | Decatur | Illinois | 62526 | — |
| Edward Cancer Center | Naperville | Illinois | 60540 | — |
| Mid-Illinois Hematology & Oncology Associates, Ltd | Normal | Illinois | 61761 | — |
| University Of Iowa Hospitals And Clinics | Iowa City | Iowa | 52242 | — |
| Siouxland Hematology-Oncology Assoc., Llp | Sioux City | Iowa | 51101 | — |
| Hutchinson Clinic, Pa | Hutchinson | Kansas | 67502 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| The Bunting-Blaustein Cancer Research Building | Baltimore | Maryland | 21231 | — |
| Frederick Memorial Hospital Regional Cancer Therapy Center | Frederick | Maryland | 21701 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Kansas City Veterans Affairs Medical Center | Kansas City | Missouri | 64128 | — |
| St Johns Medical Research Institute, Inc. | Springfield | Missouri | 65807 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Raleigh Hematology Oncology Associates | Raleigh | North Carolina | 27607 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| University Of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| St. Luke'S Hospital & Health Network Laboratory | Bethlehem | Pennsylvania | 18015 | — |
| Va Pittsburgh Healthcare System | Pittsburgh | Pennsylvania | 15240 | — |
| Associates In Hematology & Oncology, P.C. | Upland | Pennsylvania | 19013 | — |
| Musc Hollings Cancer Center | Charleston | South Carolina | 29445 | — |
| Center For Oncology Research & Treatment, P.A. | Dallas | Texas | 75230 | — |
| The Center For Cancer And Blood Disorders | Fort Worth | Texas | 76104 | — |
| The University Of Texas Md Anderson Cancer Center | Houston | Texas | 77030 | — |
| Northwest Cancer Center | Houston | Texas | 77090 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Edwards Comprehensive Cancer Center | Huntington | West Virginia | 25701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00861614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2016 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00861614 live on ClinicalTrials.gov.